June 4, 2025 Kigali, Rwanda and San Francisco, USA

Eric Karikari – Boateng, MSc, Head of Global Regulatory Strategy at Bio Usawa (BUI), and Elise Brownell, PhD, Chief of Staff, lead the Company’s Executive team in celebrating Dr. Darko’s appointment to Director General of the AMA.

“I am thrilled to extend my warmest congratulations to Dr. Mimi Darko on her historic appointment as the Director-General of the African Medicines Agency (AMA)! This well-deserved achievement is a testament to her exceptional leadership, dedication to public health, and unwavering commitment to advancing healthcare standards in Ghana and across Africa. Under her visionary guidance at the Ghana FDA, she has set a remarkable precedent advancing the agency to achieve ML3 and I have no doubt she will drive transformative change at AMA. Wishing her immense success as she takes on this pivotal role in shaping the future of medicine regulation on the continent,” remarked Mr. Karikari-Boateng.

Congratulations, Dr. Darko, from all of us at Bio Usawa!

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.